Translink Corporate Finance is pleased to announced the sale of Group WEB100T to the Italian Group Dedalus. Translink acted as the exclusive financial adviser to the shareholders of Groupe WEB100T.
Established in 2003, Groupe Web100T is a leading software company dedicated to creating solutions clinical information system and patient administration system, primarily for private healthcare, but also for ESPIC and public healthcare. Almost 20 years later, the group has become a leader on the private healthcare market and now supplies its solutions to leading private clinic groups such as ELSAN and VIVALTO. The success of the group mostly relies on a full web architecture for all their software, and large and consistent investments in R&D over the last 15 years.
Dedalus France, and its majority shareholders Dedalus (an Italian company owned by Ardian Buy Out (60%) and HHC srl (Giorgio Moretti, founder – 40%)), is a leading international Industrial Group in the clinical healthcare software field and holds a primary position in market segments of both public and private healthcare.
Less than 24 months after a minority LBO with ISATIS Capital, and after a short and intense process carried over the first semester of 2019, Groupe Web100T is now part of the European leader in clinical healthcare software. « Joining forces with Dedalus and being part of their very ambitious growth strategy is a fantastic opportunity for us and our clients. It clearly reflects our long-term strategy of being the leader on the private clinic market. For us, this transaction is key in keeping building our competitive advantage based on our technology and our business expertise, especially today as the market is consolidating faster and clients are getting bigger. », states Frédéric Gravereaux, founder of Groupe Web100T. The latter will join the board of Dedalus France to assist Dedalus Group on its future projects in France.
Thanks to this acquisition, Dedalus France enters the private clinic market in France, and acquires the most efficient and performant PMSI solution on the market. Numerous cross selling and up selling synergies have already been identified and will be implemented quickly in the coming months.
« We’re very happy to welcome Web100T team members in Dedalus Group. Our new solutions, with our D4 platform, will clearly benefit from the expertise developed in Web100T’s solutions. Over the past 4 years, Dedalus invested large amounts in R&D, and will keep on doing so in the coming years. Dedalus aims at offering state of the art solution, both technically and in terms of functionalities. We are preparing a revolution for clinical software », says Giorgio Moretti, CEO of Dedalus Group.
« We’re very happy about this transaction. It clearly confirms the strategic value and the strong position of Web100T on the market. The transaction values the high level of expertise of the team and the strategy lead by the management since we acquired a minority of the shares. Together with Dedalus, Web100T will clearly be able to tackle new opportunities. » adds Laurent Baudino, Partner at ISATIS Capital.
For Financière Monceau Translink CF France, it is the fourth transaction closed in the healthcare software industry. « The consolidation of the healthcare market is still very active between private clinics, and the French government is putting the software companies under a lot of pressure with regards to new regulations. This leads to a consolidation movement between the software providers. And high valuation and strong premium for the leaders also contributes to a very active M&A market. » says Marc Irisson, Partner in charge of the TMT industries at Financière Monceau Translink CF France. The transaction was completed with the support of our Italian office (David Strempel, Partner).
Contact our Team Members having supported this transaction: